– 
Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Combination therapy has been a central component of treatment for certain viral diseases for more than 15 years. Full Article at Xconomy
Related Articles
-
--In Vitro Results presented in a poster session at AASLD; Phase 2 combination studies to be initiated in 2Q 2010-- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nov 3, 2009 - Drug discovery company SCYNEXIS, Inc. today presented positive data from an... Full Article at Drugs.com
-
Main Category: Liver Disease / Hepatitis Also Included In: Clinical Trials / Drug Trials Article Date: 03 Nov 2009 - 1:00 PST email to a friend printer friendly view / write opinions rate article All approved therapy regimens to treat patients... Full Article at Medical News Today
-
The triple combination of boceprevir and the current treatments of pegylated-interferon and ribavirin appeared to knock out the virus at double the rate of the standard drugs alone, according to researchers. Full Article at Times Live South Africa
Related Quotes
-
There is a strong need for additional options for hepatitis C patients
-
It’s very exciting data, but larger studies will have to confirm what we see as signals in this very small but promising study
SOURCE: Times Live South Africa -
The question is whether you are going to provide more benefits to patients by adding an ARB
SOURCE: Glam.com -
We expect that the IMO-2125 trial with ribavirin in treatment-naïve HCV patients and our ongoing IMO-2125 monotherapy trial in HCV patients who failed to respond to previous standard of care therapy will provide us with data in two HCV patient populations on safety, immunological activity, and effect on...
SOURCE: Medical News Today
